Alnajashi, H. (2025). Rituximab as an off Label, High Efficacy Therapy in The Treatment of Multiple Sclerosis and Related Central Nervous System Demyelinating Diseases: Single Centre Experience and Literature Review. Journal of Contemporary Medical Sciences, 11(3). https://doi.org/10.22317/jcms.v11i3.1892